Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 350 | 303 | 314 | N/A | N/A |
| Accounts receivable | -76 | -55 | -20 | -37 | 234 |
| Accounts payable and accrued liabilities | 303 | 282 | 24 | 1,258 | -7 |
| Other Working Capital | 92 | 296 | -45 | 1,153 | 148 |
| Other Operating Activity | -1,143 | -1,272 | -423 | -2,114 | -696 |
| Operating Cash Flow | $-474 | $-448 | $-150 | $260 | $-321 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | N/A | N/A | -2 | -8 |
| Net Acquisitions | 0 | 2,192 | 0 | -468 | 0 |
| Purchase Sale Intangibles | 0 | 0 | 0 | -3 | -6 |
| Other Investing Activity | 0 | 0 | 0 | -118 | -97 |
| Investing Cash Flow | $0 | $2,192 | $0 | $-591 | $-111 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 221 | N/A | 0 | 0 |
| Debt Issued | 0 | 0 | 250 | 0 | 0 |
| Debt Repayment | -1,492 | -11 | -10 | N/A | N/A |
| Common Stock Issued | 200 | 0 | 0 | -4,740 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 4,720 | 0 |
| Financing Cash Flow | $-1,292 | $211 | $240 | $-20 | $0 |
| Exchange Rate Effect | -128 | 191 | -145 | 61 | -28 |
| Beginning Cash Position | 2,163 | 18 | 74 | 364 | 824 |
| End Cash Position | 269 | 2,163 | 18 | 74 | 364 |
| Net Cash Flow | $-1,766 | $1,955 | $89 | $-351 | $-431 |
| Free Cash Flow | |||||
| Operating Cash Flow | -474 | -448 | -150 | 260 | -321 |
| Capital Expenditure | N/A | N/A | 0 | -5 | -14 |
| Free Cash Flow | -474 | -448 | -150 | 255 | -335 |